Latham & Watkins LLP represented the underwriters in the offering. Foghorn Therapeutics Inc. has announced the pricing of its initial public offering of 7,500,000 shares of…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now